The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Cancer gene therapy: fringe or cutting edge?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“Loss of TP53 increases the rates of spontaneous cancers tremendousl”
BackgroundDruker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,760
Self-citationThe EGF receptor family as targets for cancer therapy
Mendelsohn, J., & Baselga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1204082 · Cited by 1,340
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,101
Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301205 · Cited by 976
Moolten, F. L. (1986) · PubMed · Cited by 972
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Becelaere, K. V., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., et al. (1999) · Nature Medicine · doi:10.1038/10533 · Cited by 970
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
Induction of the growth inhibitor IGF-binding protein 3 by p53
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B. R., & Kley, N. (1995) · Nature · doi:10.1038/377646a0 · Cited by 869
Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas
Mineta, T., Rabkin, S. D., Yazaki, T., Hunter, W. D., & Martuza, R. L. (1995) · Nature Medicine · doi:10.1038/nm0995-938 · Cited by 822
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
Fueyo, J., Gomez-Manzano, C., Alemany, R., Lee, P. S., McDonnell, T. J., Mitlianga, P., Shi, Y.-X., Levin, V. A., Yung, W. K. A., & Kyritsis, A. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203251 · Cited by 764
Mutations in the APC tumour suppressor gene cause chromosomal instability
Fodde, R., Kuipers, J., Rosenberg, C., Smits, R., Kielman, M., Gaspar, C., van Es, J. H., Breukel, C., Wiegant, J., Giles, R. H., et al. (2001) · Nature Cell Biology · doi:10.1038/35070129 · Cited by 723
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., et al. (1996) · Nature Medicine · doi:10.1038/nm0996-985 · Cited by 703
Rainov, N. G. (2000) · Human Gene Therapy · doi:10.1089/104303400750038499 · Cited by 698
Rampling, R., Cruickshank, G., Papanastassiou, V, Nicoll, J., Hadley, D., Brennan, D., Petty, R., MacLean, A., Harland, J., McKie, E., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301184 · Cited by 598
Rodríguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., & Henderson, D. (1997) · PubMed · Cited by 584
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
Heise, C., Hermiston, T., Johnson, L., Brooks, G., Sampson-Johannes, A., Williams, A., Hawkins, L., & Kirn, D. (2000) · Nature Medicine · doi:10.1038/80474 · Cited by 583
A role for the Adenomatous Polyposis Coli protein in chromosome segregation
Kaplan, K. B., Burds, A. A., Swedlow, J. R., Bekir, S. S., Sorger, P. K., & Näthke, I. S. (2001) · Nature Cell Biology · doi:10.1038/35070123 · Cited by 545
Kirn, D., Martuza, R. L., & Zwiebel, J. (2001) · Nature Medicine · doi:10.1038/89901 · Cited by 502
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
Swisher, S. G., Roth, J. A., Nemunaitis, J., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Connors, D. G., El-Naggar, A. K., Fossella, F., Glisson, B. S., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.763 · Cited by 496
Apoptosis and APC in colorectal tumorigenesis.
Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7950 · Cited by 489
Nemunaitis, J., Khuri, F., Ganly, I., Arseneau, J., Posner, M., Vokes, E., Kuhn, J., McCarty, T., Landers, S., Blackburn, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.289 · Cited by 471
Structural Analysis of the Mechanism of Adenovirus Binding to Its Human Cellular Receptor, CAR
Bewley, M. C., Springer, K., Zhang, Y.-B., Freimuth, P., & Flanagan, J. M. (1999) · Science · doi:10.1126/science.286.5444.1579 · Cited by 448
Blood clearance rates of adenovirus type 5 in mice
Alemany, R., Suzuki, K., & Curiel, D. T. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-11-2605 · Cited by 413
Barker, D., & Berk, A. J. (1987) · Virology · doi:10.1016/0042-6822(87)90441-7 · Cited by 385
Efficient Gene Transfer into Human CD34 + Cells by a Retargeted Adenovirus Vector
Shayakhmetov, D. M., Papayannopoulou, T., Stamatoyannopoulos, G., & Lieber, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2567-2583.2000 · Cited by 367
Growth retardation and tumour inhibition by BRCA1
Holt, J. T., Thompson, M. E., Szabo, C., Robinson-Benion, C., Arteaga, C. L., King, M.-C., & Jensen, R. A. (1996) · Nature Genetics · doi:10.1038/ng0396-298 · Cited by 361
The Murine CAR Homolog Is a Receptor for Coxsackie B Viruses and Adenoviruses
Bergelson, J. M., Krithivas, A., Celi, L., Droguett, G., Horwitz, M. S., Wickham, T., Crowell, R. L., & Finberg, R. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.415-419.1998 · Cited by 359
Rothmann, T., Hengstermann, A., Whitaker, N. J., Scheffner, M., & zur Hausen, H. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9470-9478.1998 · Cited by 353
Ikeda, K., Ichikawa, T., Wakimoto, H., Silver, J. S., Deisboeck, T. S., Finkelstein, D., Harsh, G. R., Louis, D. N., Bartus, R. T., Hochberg, F. H., et al. (1999) · Nature Medicine · doi:10.1038/11320 · Cited by 339
Freytag, S. O., Rogulski, K. R., Paielli, D. L., Gilbert, J. D., & Kim, J. H. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.9-1323 · Cited by 337
Nemunaitis, J., Swisher, S. G., Timmons, T., Connors, D., Mack, M., Doerksen, L., Weill, D., Wait, J., Lawrence, D. D., Kemp, B. L., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.609 · Cited by 322
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
Fisher, K., Stallwood, Y., Green, N., Ulbrich, K., Mautner, V, & Seymour, L. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301389 · Cited by 316
Fechner, H., Haack, A., Wang, H., Wang, X., Eizema, K., Pauschinger, M., Schoemaker, R. G., van Veghel, R., Houtsmuller, A. B., Schultheiss, H.-P., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301030 · Cited by 310
Sandmair, A.-M., Loimas, S., Puranen, P., Immonen, A., Kossila, M., Puranen, M., Hurskainen, H., Tyynelä, K., Turunen, M., Vanninen, R., et al. (2000) · Human Gene Therapy · doi:10.1089/104303400750035726 · Cited by 300
p53 Status Does Not Determine Outcome of E1B 55-Kilodalton Mutant Adenovirus Lytic Infection
Goodrum, F. D., & Ornelles, D. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9479-9490.1998 · Cited by 289
p53-Independent and -Dependent Requirements for E1B-55K in Adenovirus Type 5 Replication
Harada, J. N., & Berk, A. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5333-5344.1999 · Cited by 259
Zhang, W. W., Fang, X., Mazur, W. M., French, B. A., Georges, R. N., & Roth, J. A. (1994) · PubMed · Cited by 257
Bouvet, M., Ellis, L. M., Nishizaki, M., Fujiwara, T., Liu, W., Bucana, C. D., Fang, B., Lee, J. J., & Roth, J. A. (1998) · PubMed · Cited by 242
Kurihara, T., Brough, D. E., Kovesdi, I., & Kufe, D. W. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9180 · Cited by 238
Honda, T., Saitoh, H., Masuko, M., Katagiri-Abe, T., Tominaga, K., Kozakai, I., Kobayashi, K., Kumanishi, T., Watanabe, Y. G., Odani, S., et al. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00036-x · Cited by 234
Virus-mediated killing of cells that lack p53 activity
Raj, K., Ogston, P., & Beard, P. (2001) · Nature · doi:10.1038/35091082 · Cited by 207
Tumor-Specific, Replication-Competent Adenovirus Vectors Overexpressing the Adenovirus Death Protein
Doronin, K., Toth, K., Kuppuswamy, M., Ward, P., Tollefson, A. E., & Wold, W. S. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.6147-6155.2000 · Cited by 206
Bridgewater, J. A., Springer, C. J., Knox, R. J., Minton, N. P., Michael, N. P., & Collins, M. K. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00436-x · Cited by 205
Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
Ries, S. J., Brandts, C. H., Chung, A. S., Biederer, C. H., Hann, B. C., Lipner, E. M., McCormick, F., & Michael Korn, W. (2000) · Nature Medicine · doi:10.1038/80466 · Cited by 189
Self-citationSuppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
Cheney, I. W., Johnson, D. E., Vaillancourt, M. T., Avanzini, J. B., Morimoto, A. M., Demers, G. W., Wills, K. N., Shabram, P. W., Bolen, J. B., Tavtigian, S. V., et al. (1998) · PubMed · Cited by 188
Chen, Q.-R., Kumar, D., Stass, S. A., & Mixson, A. J. (1999) · PubMed · Cited by 181
Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel.
Yu, D., Chen, Y., Dilley, J., Li, Y., Embry, M. G., Zhang, H., Nguyen, N. N. M., Amin, P., Oh, J., & Henderson, D. (2001) · PubMed · Cited by 173
Trinh, Q. T., Austin, E. A., Murray, D. M., Knick, V. C., & Huber, B. E. (1995) · PubMed · Cited by 172
Intralesional injection of herpes simplex virus 1716 in metastatic melanoma
MacKie, R. M., Stewart, B., & Brown, S. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04048-4 · Cited by 171
Barrington, R. E., Subler, M. A., Rands, E., Omer, C. A., Miller, P. J., Hundley, J. E., Koester, S. K., Troyer, D. A., Bearss, D. J., Conner, M. W., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.85 · Cited by 171
Wildner, O., Morris, J. C., Vahanian, N. N., Jr, H. F., Ramsey, W. J., & Blaese, R. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300810 · Cited by 170
Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector
Parr, M. J., Manome, Y., Tanaka, T., Wen, P., Kufe, D. W., Kaelin, W. G., & Fine, H. A. (1997) · Nature Medicine · doi:10.1038/nm1097-1145 · Cited by 169
Chen, Y., Yu, D., Charlton, D., & Henderson, D. (2000) · Human Gene Therapy · doi:10.1089/10430340050083289 · Cited by 143
Aghi, M. K., Cho, T.-C., Chiocca, E. A., Kramm, C. M., & Breakefield, X. O. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.5.370 · Cited by 143
Takayama, K., Ueno, H., Nakanishi, Y., Sakamoto, T., Inoue, K., Shimizu, K., Oohashi, H., & Hara, N. (2000) · PubMed · Cited by 142
Adenovirus-Mediated p14ARF Gene Transfer in Human Mesothelioma Cells
Yang, C., You, L., Yeh, C., Chang, J. W. C., Zhang, F., McCormick, F. P., & Jablons, D. M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.8.636 · Cited by 138
Self-citationLudwig, A., Saretzki, G. C., Holm, P. S., Tiemann, F., Lorenz, M., Emrich, T., Harley, C. B., & von Zglinicki, T. (2001) · PubMed · doi:10.25405/ncl.34663959 · Cited by 138
Induction of apoptosis by the tumor suppressor protein BRCA1.
Shao, N., Chai, Y. L., Shyam, E., Reddy, P., & Rao, V. N. (1996) · PubMed · Cited by 137
Aghi, M. K., Chou, T., Suling, K. M., Breakefield, X. O., & Chiocca, E. A. (1999) · PubMed · Cited by 124
The p53 Tumor Suppressor Gene Inhibits Angiogenesis by Stimulating the Production of ThrombospondinPreprint
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.053 · Cited by 123
Craig, C., Kim, M., Ohri, E., Wersto, R. P., Katayose, D., Li, Z., Choi, Y. H., Mudahar, B., Srivastava, S. K., Seth, P. K., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201493 · Cited by 123
Turnell, A. S., Grand, R. J. A., & Gallimore, P. H. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2074-2083.1999 · Cited by 123
Nikitin, A. Y., Juarez-Perez, M. I., Li, S., Huang, L., & Lee, W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3916 · Cited by 120
Osteocalcin-directed gene therapy for prostate-cancer bone metastasis
Koeneman, K. S., Kao, C. H., Ko, S.-C., Yang, L., Wada, Y., Kallmes, D. F., Gillenwater, J. Y., Zhau, H. E., Chung, L. W. K., & Gardner, T. A. (2000) · World Journal of Urology · doi:10.1007/s003450050181 · Cited by 120
Gotoh, A., Ko, S.-C., Shirakawa, T., Cheon, J., Kao, C. H., Miyamoto, T., Gardner, T. A., Ho, L., Cleutjens, C. B. J. M., Trapman, J., et al. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63094-5 · Cited by 120
Crystal, R. G., Hirschowitz, E. A., Lieberman, M., Daly, J. M., Kazam, E., Henschke, C. I., Yankelevitz, D. F., Kemeny, N. E., Silverstein, R. L., Ohwada, A., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.8-985 · Cited by 119
Nishizaki, M., Fujiwara, T., Tanida, T., HIZUTA, A., Nishimori, H., Tokino, T., Nakamura, Y., Bouvet, M., Roth, J., & Tanaka, N. (1999) · PubMed · doi:10.11501/3168375 · Cited by 118
Majumdar, A. S., Hughes, D. E., Lichtsteiner, S., Wang, Z., LEBKOWSKI, J. S., & Vasserot, A. P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301421 · Cited by 114
Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
Ll, N., Dell, J., Maxwell, E., et al. (1997) · PubMed · Cited by 114
You, L., Yang, C., & Jablons, D. M. (2000) · PubMed · Cited by 106
Replicating viruses as selective cancer therapeutics
Kirn, D. H., & McCormick, F. (1996) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)81456-6 · Cited by 104
Self-citationBrand, K., Baker, A. H., Pérez‐Canto, A., Possling, A., Sacharjat, M., Geheeb, M., & Arnold, W. (2000) · PubMed · Cited by 103
Tanaka, M., Koul, D., Davies, M. A., Liebert, M., Steck, P. A., & Grossman, H. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203918 · Cited by 103
Touraine, R. L., Vahanian, N. N., Ramsey, W. J., & Blaese, R. M. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.16-2385 · Cited by 102
Ido, A., Uto, H., Moriuchi, A., Nagata, K., Onaga, Y., Onaga, M., Hori, T., Hirono, S., Hayashi, K., Tamaoki, T., et al. (2001) · PubMed · Cited by 96
Riley, D. J., Nikitin, A. Y., & Lee, W. (1996) · Nature Medicine · doi:10.1038/nm1296-1316 · Cited by 91
Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11.
Danks, M. K., Morton, C. L., Pawlik, C. A., & Potter, P. M. (1998) · PubMed · Cited by 90
Chen, C. T., Lin, J., Li, Q., Phipps, S. S., Jakubczak, J. L., Stewart, D. A., Skripchenko, Y., Forry‐Schaudies, S., Wood, J. M., Schnell, C., et al. (2000) · Human Gene Therapy · doi:10.1089/10430340050143417 · Cited by 88
Tang, C. K., Concepcion, X. Z. W., Milan, M., Gong, X., Montgomery, E. A., & Lippman, M. E. (1999) · PubMed · Cited by 86
Does the Antitumor Adenovirus ONYX-015/dl1520 Selectively Target Cells Defective in the p53 Pathway?
Dix, B. R., Edwards, S. J., & Braithwaite, A. W. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5443-5447.2001 · Cited by 85
Gnant, M., Puhlmann, M., Alexander, H. R., & Bartlett, D. L. (1999) · PubMed · Cited by 82
Manome, Y., Kunieda, T., Wen, P. Y., Koga, T., Kufe, D. W., & Ohno, T. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.10-1409 · Cited by 80
Jiang, W. G., Grimshaw, D., Lane, J., Martin, T. A., Abounader, R., Laterra, J., Mansel, R. E., & Abounder, R. (2001) · PubMed · Cited by 79
McCormick, F. P. (2001) · Nature · doi:10.1038/35085665 · Cited by 72
Self-citationCYTOCHROME P450-BASED CANCER GENE THERAPY: RECENT ADVANCES AND FUTURE PROSPECTS
Waxman, D. J., Chen, L., Hecht, J. E. D., & Jounaïdi, Y. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101933 · Cited by 67
Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene.
Minaguchi, T., Mori, T., Kanamori, Y., Matsushima, M., Yoshikawa, H., Taketani, Y., & Nakamura, Y. (1999) · PubMed · Cited by 53
Tumor necrosis factor as an antineoplastic agent: pitfalls and promises
Mueller, H. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050255 · Cited by 53
Kataoka, M., Schumacher, G., Cristiano, R. J., Atkinson, E. N., Roth, J. A., & Mukhopadhyay, T. (1998) · PubMed · Cited by 51
Claudio, P. P., Stiegler, P., Howard, C. M., Bellan, C., Minimo, C., Tosi, G. M., Rak, J. W., Kovatich, A. J., Fazio, P. D., Micheli, P., et al. (2001) · PubMed · Cited by 48
Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
Chen, R., & McCormick, F. (2001) · PubMed · Cited by 45
Self-citationZhang, Y. P., Nemunaitis, J. J., Kj, S., & Tong, A. W. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301331 · Cited by 44
A glial-specific, repressible, adenovirus vector for brain tumor gene therapy.
Chen, J., Bezdek, T., Chang, J., Kherzai, A., Willingham, T., Azzara, M., & Nisen, P. D. (1998) · PubMed · Cited by 43
McKie, E. A., Graham, D. I., & Brown, S. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300621 · Cited by 42
Seth, P. K., Katayose, D., Li, Z., Kim, M., Wersto, R. P., Craig, C., Shanmugam, N., Ohri, E., Mudahar, B., Rakkar, A. N. S., et al. (1997) · PubMed · Cited by 41
Therapeutic Efficacy of an Adenovirus-Mediated Anti-H- ras Ribozyme in Experimental Bladder Cancer
Irie, A., Anderegg, B., Kashani–Sabet, M., OHKAWA, T., SUZUKI, T., Halks‐Miller, M., Curiel, D., & Kj, S. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.341 · Cited by 38
Zhang, R., Straus, F. H., & DeGroot, L. J. (2001) · Thyroid · doi:10.1089/105072501300042749 · Cited by 36
Use of von Willebrand Factor Promoter to Transduce Suicidal Gene to Human Endothelial Cells, HUVEC
Ozaki, K., Yoshida, T., Ide, H., Saito, I., Ikeda, Y., Sügimura, T., & Terada, M. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.13-1483 · Cited by 35
Block, A., Freund, C. T. F., Chen, S., Nguyen, K.-P., Finegold, M. J., Windler, E., & Woo, S. L. C. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700131 · Cited by 28
Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors
Kunke, D., Grimm, D., Denger, S., Kreuzer, J., Delius, H., Komitowski, D. D., & Kleinschmidt, J. A. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700178 · Cited by 28
Sumitomo, K., Shimizu, E., Shinohara, A., Yokota, J., & Sone, S. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.6.1075 · Cited by 23
Funato, T., Ishii, T., Kambe, M., Scanlon, K. J., & Sasaki, T. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700125 · Cited by 23
Suzuki, S., Tadakuma, T., Asano, T., & Hayakawa, M. (2001) · PubMed · Cited by 14
住友, 賢. (2000) · Medical Entomology and Zoology · doi:10.11501/3167798 · Cited by 3
Cited by
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Self-citationTranscription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
TRAIL and apoptosis induction by TNF-family death receptors
Wang, S., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1207232 · Cited by 871
Metadata
- Authors
- McCormick, F.
- Venue
- Nature Reviews Cancer
- Published
- 2001-11-01
- Volume
- 1
- Issue
- 2
- Pages
- 130-141
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1540542144
- Cited by
- 346
- References
- 105
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.